MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0093556
Blue Biopharma Limited
Blue Biopharma Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹2.28 Lakh
▼ 18% YoY
Net profit · FY 2022
₹2,550
Net margin 1.1%
EBITDA · FY 2022
₹3,920
EBITDA margin 1.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Blue Biopharma Limited
Data last updated:
Blue Biopharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74110TG2010PLC070262.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Jagdishraj Ramchand Mahajan and Anil Kumar Gopalakrishna Madrahalli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 – 5 – 171 Hasmat Gunj Sultan Bazaar Koti, Hyderabad, Telangana, India – 500095.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.28 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹2,550 (net margin 1.1%) and EBITDA of ₹3,920 (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
Blue Biopharma Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0093556). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74110TG2010PLC070262
Registration Number 070262
Incorporation Date 01 September 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0093556
CIN history
Blue Biopharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74110TG2010PLC070262, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110TG2010PLC070262 | Current |
| U24233AP2010PLC070262 | Previous |
| U24233TG2010PLC070262 | Previous |
Key People
Jagdishraj Ramchand Mahajan Director Anil Kumar Gopalakrishna Madrahalli Director Chitguppa Ramakanth Director Recognitions & Rankings of Blue Biopharma
Contact details
Blue Biopharma Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4 – 5 – 171 Hasmat Gunj Sultan Bazaar Koti, Hyderabad, Telangana, India – 500095
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Blue Biopharma Limited, buy the company report.
Comprehensive company report
Blue Biopharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Blue Biopharma Limited
FY 2025 filings availableBlue Biopharma Limited reported revenue of ₹2.28 Lakh (down 18% YoY) for FY 2022.
Revenue · FY 2022
₹2.28 Lakh ▼ 18%
Net profit · FY 2022
₹2,550 margin 1.1%
EBITDA · FY 2022
₹3,920 margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 4%
5 years · compounded
▲ 25%
Revenue has declined at a compounded annual rate (CAGR) of 2% over three years, including a 18% fall in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.28 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,920 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,550 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blue Biopharma Limited, buy the company report.
Board of directors of Blue Biopharma Limited
Blue Biopharma has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdishraj Ramchand Mahajan | Director | 17 Sep 2018 | 8 Years 1 Months | Current |
| Anil Kumar Gopalakrishna Madrahalli | Director | 29 Nov 2021 | 4 Years 10 Months | Current |
| Chitguppa Ramakanth Also directs: R-Gem Life Sciences Private Limited | Director | 29 Nov 2021 | 4 Years 10 Months | Current |
Peer comparison
Blue Biopharma Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Biopharma, Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Loral Pharma Private Limited | ₹2.33 Lakh (FY 2025) | -82.0% | Mumbai, Maharashtra, India | |||
| Genprotic Biopharma Private Limited | ₹2.32 Lakh (FY 2024) | -70.0% | Uthandi, Tamil Nadu, India | |||
| Grit Healthcare Private Limited | ₹2.31 Lakh (FY 2018) | 57.0% | Bhiwani, Haryana, India | |||
| Virgo Formulations Private Limited | ₹2.28 Lakh (FY 2025) | 152.0% | Meerut, Uttar Pradesh, India | |||
| Anvit Pharma Private Limited | ₹2.28 Lakh (FY 2016) | -98.0% | Hyderabad, Telangana, India | |||
| Blue Biopharma Limitedthis company | ₹2.28 Lakh (FY 2022) | ₹2,550 | 1.1% | -18.0% | Hyderabad, Telangana, India | |
| Meark Pharma Private Limited | ₹2.26 Lakh (FY 2024) | 121.0% | Ahmedabad, Gujarat, India | |||
| Kommareddi Biopharma Private Limited | ₹2.25 Lakh (FY 2020) | 592.0% | Hyderabad, Telangana, India | |||
| Goodhealth Pharmaceuticals Private Limited | ₹2.25 Lakh (FY 2025) | 487.0% | Delhi, India | |||
| Indo Global Lifesciences Private Limited | ₹2.25 Lakh (FY 2022) | 5517.0% | Thane, Maharashtra, India | |||
| Mahadev Drugs Gujarat Private Limited | ₹2.2 Lakh (FY 2025) | -93.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Blue Biopharma Limited, buy the company report.
Auditor
Blue Biopharma Limited is audited by PUNDARIKASHYAM & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PUNDARIKASHYAM & ASSOCIATES | FY 2022 | 011330S |
Shareholding
The shareholding of Blue Biopharma Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Blue Biopharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Blue Biopharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blue Biopharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Blue Biopharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Blue Biopharma Limited has 11 board changes on record since 2015: 3 appointments and 8 cessations. The latest: Joseph Thady ceased to be Director on 15 Dec 2021.
AGM
Blue Biopharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Blue Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Joseph Thady ceased to be Director.
Ceased
Rajesh Limbachiya Chandrakant ceased to be Director.
Ceased
Anil Kumar Gopalakrishna Madrahalli ceased to be Additional Director.
Ceased
Chitguppa Ramakanth ceased to be Additional Director.
Appointed
Anil Kumar Gopalakrishna Madrahalli was appointed as Director.
Appointed
Chitguppa Ramakanth was appointed as Director.
Ceased
Madhavapeddi Durga Prasad ceased to be Director.
Ceased
Ramesh Meesala ceased to be Additional Director.
Ceased
Varre Durga Jagan Mohan Rao ceased to be Director.
Appointed
Jagdishraj Ramchand Mahajan was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Blue Biopharma is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 September 2010 (16+ years old) and is registered under CIN U74110TG2010PLC070262.
Blue Biopharma has 3 current directors:
- Jagdishraj Ramchand Mahajan - Director
- Anil Kumar Gopalakrishna Madrahalli - Director
- Chitguppa Ramakanth - Director
The latest financial statements of Blue Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Blue Biopharma is U74110TG2010PLC070262. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blue Biopharma was incorporated on 01 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Blue Biopharma by revenue are Loral Pharma Private Limited, Genprotic Biopharma Private Limited, Grit Healthcare Private Limited, Virgo Formulations Private Limited, Anvit Pharma Private Limited and 5 more, all in the Pharma industry (Biopharma, Formulations).
Joseph Thady ceased to be Director on 15 Dec 2021. Rajesh Limbachiya Chandrakant ceased to be Director on 15 Dec 2021. Anil Kumar Gopalakrishna Madrahalli ceased to be Additional Director on 30 Nov 2021. Blue Biopharma has 11 board changes on record in total.
Yes, Blue Biopharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0093556).
The registered office of Blue Biopharma is at 4 – 5 – 171 Hasmat Gunj Sultan Bazaar Koti, Hyderabad, Telangana, India – 500095.
Blue Biopharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Blue Biopharma is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.